#235 (Feb. 04, 2026) 'The Peptide Era: Healing, Evidence, and the Future of Care': IMA (formerly FLCCC) Weekly Show
Thu Feb 05 2026
Peptides are increasingly part of conversations around healing, recovery, and chronic disease care — yet many patients and clinicians still have questions about what they are, how they work, and when they’re most appropriate.
In this episode, Dr. Kristina Carman, IMA Senior Fellow, leads a focused discussion with Dr. (JP) Yusuf Saleeby, IMA Senior Fellow in Functional and Integrative Medicine, and Dr. Daniel Bahnmiller, OBGYN and Medical Director, examining how peptides are being thoughtfully integrated into modern clinical practice.
Topics include:
• How peptides work as signaling molecules
• Clinical areas where peptides may offer meaningful benefit
• Patient selection and foundational health considerations
• Safety, ethics, and long-term thinking
• The evolving role of peptides in evidence-informed care
A clear, balanced conversation designed to inform, educate, and bring confidence to an evolving area of medicine.
Also:
• Donate: https://imahealth.org/donate/
• Follow: https://imahealth.org/contact/
• Webinar: https://imahealth.org/category/weekly-webinars/
• Treatment: https://imahealth.org/treatment-protocols/
• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/
About IMA (Formerly FLCCC Alliance)
The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization’s mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.
For more information about the Independent Medical Alliance, visit www.IMAhealth.org
More
Peptides are increasingly part of conversations around healing, recovery, and chronic disease care — yet many patients and clinicians still have questions about what they are, how they work, and when they’re most appropriate. In this episode, Dr. Kristina Carman, IMA Senior Fellow, leads a focused discussion with Dr. (JP) Yusuf Saleeby, IMA Senior Fellow in Functional and Integrative Medicine, and Dr. Daniel Bahnmiller, OBGYN and Medical Director, examining how peptides are being thoughtfully integrated into modern clinical practice. Topics include: • How peptides work as signaling molecules • Clinical areas where peptides may offer meaningful benefit • Patient selection and foundational health considerations • Safety, ethics, and long-term thinking • The evolving role of peptides in evidence-informed care A clear, balanced conversation designed to inform, educate, and bring confidence to an evolving area of medicine. Also: • Donate: https://imahealth.org/donate/ • Follow: https://imahealth.org/contact/ • Webinar: https://imahealth.org/category/weekly-webinars/ • Treatment: https://imahealth.org/treatment-protocols/ • Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/ About IMA (Formerly FLCCC Alliance) The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization’s mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system. For more information about the Independent Medical Alliance, visit www.IMAhealth.org